Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelu Zhou

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The American Journal of Pathology|January 4, 2026
PPARα Deficiency Induces Vascular Pathologies through Endothelial Senescence in Diabetic RetinopathyLeimeng Xu, Rui Cheng, Kelu Zhou, et al.
Photoacoustics|October 13, 2025
PMUT enhanced light-induced thermoelastic spectroscopyWei Wei, Kelu Zhou, Ruyue Cui, et al.
Cells|December 11, 2022
The Protective Role of Microglial PPARα in Diabetic Retinal Neurodegeneration and Neurovascular DysfunctionTian Yuan, Lijie Dong, Elizabeth A Pearsall, et al.
Investigative Ophthalmology & Visual Science|October 6, 2017
Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular DegenerationFangfang Qiu, Greg Matlock, Qian Chen, et al.
Diabetes|December 18, 2020
Interphotoreceptor Retinol-Binding Protein Ameliorates Diabetes-Induced Retinal Dysfunction and Neurodegeneration Through RhodopsinJianglei Chen, Yan Shao, Temmy Sasore, et al.
Biology|December 24, 2021
Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and NeovascularizationLi Huang, Wentao Liang, Kelu Zhou, et al.
Investigative Ophthalmology & Visual Science|October 6, 2017
Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic RetinopathyGuotao Deng, Elizabeth P Moran, Rui Cheng, et al.
Diabetes|March 28, 2020
Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in DiabetesH Greg Matlock, Fangfang Qiu, Volha Malechka, et al.
International Journal of Hematology|March 17, 2017
Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19<sup>+</sup> B lymphocytes in the peripheral bloodJeffrey D McBride, Xiaochen Liu, William L Berry, et al.
Microvascular Research|April 10, 2018
Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathwayFangfang Qiu, Younghwa Shin, Danyang Chen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The American Journal of Pathology|January 4, 2026
PPARα Deficiency Induces Vascular Pathologies through Endothelial Senescence in Diabetic RetinopathyLeimeng Xu, Rui Cheng, Kelu Zhou, et al.
Photoacoustics|October 13, 2025
PMUT enhanced light-induced thermoelastic spectroscopyWei Wei, Kelu Zhou, Ruyue Cui, et al.
Cells|December 11, 2022
The Protective Role of Microglial PPARα in Diabetic Retinal Neurodegeneration and Neurovascular DysfunctionTian Yuan, Lijie Dong, Elizabeth A Pearsall, et al.
Investigative Ophthalmology & Visual Science|October 6, 2017
Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular DegenerationFangfang Qiu, Greg Matlock, Qian Chen, et al.
Diabetes|December 18, 2020
Interphotoreceptor Retinol-Binding Protein Ameliorates Diabetes-Induced Retinal Dysfunction and Neurodegeneration Through RhodopsinJianglei Chen, Yan Shao, Temmy Sasore, et al.
Biology|December 24, 2021
Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and NeovascularizationLi Huang, Wentao Liang, Kelu Zhou, et al.
Investigative Ophthalmology & Visual Science|October 6, 2017
Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic RetinopathyGuotao Deng, Elizabeth P Moran, Rui Cheng, et al.
Diabetes|March 28, 2020
Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in DiabetesH Greg Matlock, Fangfang Qiu, Volha Malechka, et al.
International Journal of Hematology|March 17, 2017
Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19<sup>+</sup> B lymphocytes in the peripheral bloodJeffrey D McBride, Xiaochen Liu, William L Berry, et al.
Microvascular Research|April 10, 2018
Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathwayFangfang Qiu, Younghwa Shin, Danyang Chen, et al.
Pageof 2